AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Dynavax Provides Update on TOLAMBA Program.
BERKELEY, Calif., March 1 /PRNewswire-FirstCall/ -- Dynavax Technologies Corporation today provided an update on key aspects of the development program for TOLAMBA(TM), a ragweed immunotherapeutic.
AAAAI Preview
Dynavax plans to report the positive safety and efficacy data from the company's Phase 2/3 clinical trial of TOLAMBA at the Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI), Saturday, March 4, 2006, in Miami, Florida.
One key data point in the upcoming presentation is the efficacy result from the interim analysis following the 2004 ragweed season (the first year of the trial). Quintiles, the contract ...
- Dynavax Reports New TOLAMBA Data at ACAAI Meeting.
- Press release article from: PR Newswire November 12, 2006 700+ words
...Dynavax is evaluating TOLAMBA in a 30-center, placebo...Dynavax Allergic Rhinitis TOLAMBA Trial) randomized subjects...three arms: the same dosing regimen that was used in the...peak ragweed season. TOLAMBA represents the foundation...
- Dynavax's TOLAMBA(TM) Demonstrates Safety in Phase 1 Trial of Ragweed Allergic...
- Press release article from: PR Newswire November 7, 2005 700+ words
...regimen used in adults. TOLAMBA is currently being...program, and using the dosing regimen equivalent to the adult...regulatory filing for TOLAMBA, pending discussions...groups treated with TOLAMBA on a dose-escalating...respectively. The dosing regimen of 1.2 to 30 ...
- Dynavax Presents Positive TOLAMBA Phase 2/3 Results at AAAAI Meeting.
- Press release article from: PR Newswire March 6, 2006 700+ words
...3 clinical trial of TOLAMBA(TM), a ragweed allergy...Dynavax plans to conduct a TOLAMBA clinical trial designed to test a more intensive dosing regimen. This trial is anticipated...Design The Phase 2/3 TOLAMBA clinical trial, initiated...
- Dynavax Announces Completion of Enrollment in TOLAMBA(TM) Ragweed Allergy Trial.
- Press release article from: PR Newswire June 7, 2006 700+ words
...upsurge in interest in the TOLAMBA trial among allergists...strength and durability of TOLAMBA's treatment effect and their optimism that TOLAMBA could provide long-term...three arms: a lower total dosing regimen consistent with the recently...
- Dynavax Falls On Phase III Tolamba Trial For Ragweed.
- Magazine article from: BIOWORLD Today Pihl-Carey, Karen January 9, 2007 700+ words
...receive either the same dosing regimen used in the Phase IIb...received six doses of Tolamba over six weeks before...Dynavax believes Tolamba can offer a benefit by its less frequent dosing regimen (once a week for six...works to determine Tolamba's future, Dynavax...
- Dynavax Reports Interim TOLAMBA(TM) Ragweed Allergy Results From DARTT Trial.
- Press release article from: PR Newswire January 8, 2007 700+ words
...ragweed, called Amb a 1. TOLAMBA is designed to target the...Dynavax Allergic Rhinitis TOLAMBA Trial) study is a 30-center...into three arms: the same dosing regimen that was used in the completed...Subjects received six doses of TOLAMBA over six weeks prior to the...
- Dynavax Introduces TOLAMBA(TM) and HEPLISAV(TM) Brand Names for Ragweed Allergy...
- Press release article from: PR Newswire September 27, 2005 700+ words
...Technologies Corporation announced the selection of TOLAMBA(TM) and HEPLISAV(TM) as brand names for...prophylaxis products, respectively. Both TOLAMBA and HEPLISAV are in Phase 3 trials. TOLAMBA and HEPLISAV are based on Dynavax's proprietary...
- Dynavax's Ragweed Allergy Therapy, TOLAMBA(TM), Achieves Primary Efficacy and...
- Press release article from: PR Newswire January 18, 2006 700+ words
...year Phase 2/3 clinical trial of TOLAMBA, a ragweed allergy immunotherapeutic, showed that patients treated with TOLAMBA experienced a statistically significant...achieve clinical benefit. Unlike the TOLAMBA-treated group, the boosted group...